14
Feb
2022
Author: bionestst
31
Jan
2022
Bionest
What’s Next for mRNA?
Beyond COVID and cancer: In which indications will we see mRNA technology succeed next? And what technological advances might next-generation mRNA platforms offer over those used in the COVID-19 vaccines?
17
Jan
2022
Bionest
Novartis and UK NHS Collaborate for Targeted Access to Levqio
Novartis is teaming up with the NHS to make the PCSK9 inhibitor Leqvio available for UK heart patients who struggle to control their LDL cholesterol with existing drugs.
27
Dec
2021
Bionest
Addressing Gene Therapy Uncertainties
Are we close to more streamlined and standardized approaches to gene therapy testing and regulations?
13
Dec
2021
Bionest
UK Policy Changes Allow Earlier Access to Innovative Medicines for Rare Diseases
Access to new treatments for rare diseases in the UK has often been a challenge. Will a new decision-making framework & funding improve the situation?
30
Nov
2021
Bionest
New Models for Primary Care
Concierge medicine? Monthly membership? Could new models of primary care help raise the quality and patient satisfaction of health care while lowering overall costs for those enrolled in commercial and government-funded insurance plans?
15
Nov
2021
Bionest
Protein Folding Determination Makes Gigantic Leap Forward
Will a new ability to rapidly decipher protein folding and picture protein structures open up new research avenues with applications in pharma R&D?
1
Nov
2021
Bionest
Increasing Diversity in Clinical Trials
A critical need exists to include more diverse populations in clinical trials to better understand the potential risks and benefits of new medicines across populations, and provide more comprehensive data sets.
18
Oct
2021
Bionest
AI Helping Clinical Cardiology with Earlier Heart Disease Detection
Advances in AI technology are helping to improve the early detection and diagnosis of a variety of cardiac conditions.
5
Oct
2021